Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Jul 10, 8:05 AMGreenland Mines’ Biotech Division secures Australian patent protection for its Klotho gene therapy technology targeting neuromuscular diseases.
Index
-
Market Cap
37.50M
Enterprise Value
27.79M
Income
-22.17M
Sales
0.00M
Book/sh
0.42
Cash/sh
0.07
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
5
IPO
Apr 29, 2022
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
0.58
P/C
3.75
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
19.74
Current Ratio
19.74
Debt/Eq
0.01
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-0.34
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
- -418.96%
Sales past 3/5Y
- -
EPS Y/Y TTM
7.75%
Sales Y/Y TTM
-
EPS Q/Q
-82.02%
Sales Q/Q
-
Earnings
-
EPS/Sales Surpr.
- -
Insider Own
17.04%
Insider Trans
-0.67%
Inst Own
7.05%
Inst Trans
10.79%
ROA
-70.71%
ROE
-85.11%
ROIC
-43.08%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
-6.90%
SMA50
-28.08%
SMA200
-38.20%
Trades
Shs Outstand
138.13M
Shs Float
127.04M
52W High
1.65 -85.16%
52W Low
0.21 19.35%
Volatility
10.19% 13.28%
ATR (14)
0.03
RSI (14)
41.31
Beta
2.53
Rel Volume
0.55
Avg Volume
3.56M
Volume
1,969,098
Perf Week
5.56%
Perf Month
-18.12%
Perf Quarter
-41.69%
Perf Half Y
-27.61%
Perf YTD
-15.26%
Perf Year
-83.23%
Perf 3Y
-97.67%
Perf 5Y
-
Perf 10Y
-
Recom
-
Target Price
-
Prev Close
0.24
Price
0.24
Change
1.24%
Jul-10-26 03:00PM
08:00AM
Jul-08-26 03:00PM
09:00AM
Jul-07-26 03:00PM
08:00AM Loading…
08:00AM
Jul-06-26 02:30PM
09:00AM
Jun-25-26 03:20PM
11:23AM
08:30AM
Jun-24-26 03:36PM
Jun-23-26 02:30PM
Jun-22-26 10:55AM
08:30AM
11:30AM Loading…
Jun-19-26 11:30AM
Jun-18-26 08:30AM
Jun-17-26 03:45PM
Jun-16-26 01:12PM
08:30AM
Jun-10-26 08:30AM
Jun-04-26 08:30AM
Jun-02-26 08:30AM
May-29-26 09:22AM
May-22-26 10:40AM
May-21-26 11:21AM
09:15AM
08:30AM
May-19-26 08:30AM
May-13-26 11:19AM
08:30AM Loading…
08:30AM
08:30AM
May-12-26 09:00AM
May-07-26 10:09AM
08:30AM
May-06-26 12:06PM
May-05-26 08:30AM
Apr-30-26 11:42AM
Apr-27-26 08:30AM
Apr-23-26 08:30AM
Apr-16-26 08:30AM
Apr-02-26 12:00PM
Mar-25-26 08:00AM
Mar-23-26 08:00AM
Mar-19-26 12:05PM
Mar-12-26 10:27AM
Mar-05-26 08:00AM
Mar-04-26 08:02AM
08:00AM
Feb-24-26 08:00AM
Feb-18-26 08:00AM
Jan-08-26 08:00AM
Nov-07-25 10:03AM
Oct-16-25 08:00AM
Oct-07-25 06:20PM
Oct-01-25 05:33AM
Sep-30-25 08:30AM
Sep-08-25 08:00AM
Aug-18-25 08:30AM
Aug-12-25 06:00AM
Jul-25-25 09:05PM
Jul-24-25 01:30PM
Jul-22-25 10:21AM
Jul-16-25 06:00AM
Jul-10-25 05:00AM
Jun-30-25 02:00AM
Jun-24-25 05:00AM
Jun-18-25 07:00AM
Jun-16-25 07:00AM
Jun-09-25 07:00AM
07:00AM
Jan-08-25 11:00AM
Dec-09-24 11:00AM
Dec-03-24 11:00AM
Oct-23-24 06:00AM
Oct-15-24 06:00AM
Sep-30-24 06:00AM
Sep-29-24 08:30PM
Sep-17-24 06:30AM
Sep-04-24 07:46AM
Aug-26-24 05:00AM
Aug-21-24 05:00AM
Aug-19-24 05:00AM
Aug-15-24 05:00AM
Aug-09-24 05:00AM
Aug-08-24 05:00AM
Jul-09-24 08:09AM
07:39AM
05:30AM
Jun-27-24 05:00AM
Jun-26-24 05:00AM
Greenland Mines Ltd. engages in the provision of new therapies to treat neurodegenerative diseases. It offers cell and gene therapy. The company was founded by Joseph Sinkule on August 2, 2004 and is headquartered in Charlotte, NC.
FounderDr. Joseph A. Sinkule Pharm.D.
Chief Financial OfficerMr. Jeffrey LeBlanc
Medical Advisor & DirectorDr. Shalom Z. Hirschman M.D.
Chief Business OfficerMr. Peter J. Moriarty
PresidentDr. Bo Moller Stensgaard
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
El-Dada Riad HusseinDirectorJun 25 '26Sale0.23175,00040,548175,000Jun 26 04:30 PM
Riad El-DadaDirectorJun 24 '26Proposed Sale0.23175,00039,935Jun 24 06:19 PM